HEC-108Homo sapiens (Human)Cancer cell line

Also known as: HEC108

🤖 AI SummaryBased on 7 publications

Quick Overview

Human endometrial cancer cell line for research on tumor biology and drug sensitivity.

Detailed Summary

HEC-108 is a human endometrial cancer cell line established from a primary tumor. It is used in research to study tumor biology, drug sensitivity, and molecular mechanisms of endometrial carcinoma. The cell line has been characterized for its growth patterns, genetic features, and response to hormonal treatments. It is part of the Cancer Cell Line Encyclopedia (CCLE) and has been utilized in studies related to gene expression, mutation analysis, and therapeutic strategies. HEC-108 exhibits specific cellular and molecular traits that make it a valuable model for investigating endometrial cancer progression and treatment responses.

Research Applications

Tumor biologyDrug sensitivityMolecular mechanismsGene expression analysisMutation analysisTherapeutic strategies

Key Characteristics

Established from primary tumorPart of CCLEUsed in hormone response studiesCharacterized for growth patternsUtilized in drug screening
Generated on 6/19/2025

Basic Information

Database IDCVCL_2923
SpeciesHomo sapiens (Human)
Tissue SourceEndometrium[UBERON:UBERON_0001295]

Donor Information

Age CategoryUnknown
SexFemale
Raceasian

Disease Information

DiseaseEndometrial adenocarcinoma
LineageUterus
SubtypeEndometrial Carcinoma
OncoTree CodeUCEC

DepMap Information

Source TypeHSRRB
Source IDACH-000990_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Pro151His (c.452C>A)Unspecified-PubMed=33802339, PubMed=11799138, PubMed=8782485, PubMed=8725545
MutationSimpleARID1Ap.Arg1446Ter (c.4336C>T)Heterozygous-Unknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11,12
D13S317
9,10,11,12,13
D16S539
11,12,13
D18S51
11,12,13
D19S433
11.2,12.2,14.2,15.2,16.2
D21S11
29,30,31
D2S1338
16,17,19,20
D3S1358
15,16,17
D5S818
6,12
D7S820
8,9,12
D8S1179
11,13
FGA
22,23
Penta D
8,9,10
Penta E
15,19,20
TH01
8,9
TPOX
11
vWA
15,16,17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Quantitative study on the correlation between p53 gene mutation and its expression in endometrial carcinoma cell lines.

Kamata Y., Watanabe J., Hata H., Hamano M., Kuramoto H.

Eur. J. Gynaecol. Oncol. 25:55-60(2004).

Three-dimensional coculture of endometrial cancer cells and fibroblasts in human placenta derived collagen sponges and expression matrix metalloproteinases in these cells.

Tanaka R., Saito T., Ashihara K., Nishimura M., Mizumoto H., Kudo R.

Gynecol. Oncol. 90:297-304(2003).

Experimental studies on the cell adhesion molecule E-cadherin and in vitro invasion of endometrial carcinoma cell lines.

Okamura N., Mori Y., Endo T., Ito E., Kudo R.

Nihon Sanka Fujinka Gakkai Zasshi 48:335-342(1996).

Establishment and characterization of human endometrial cancer cell lines.

Ohno E., Iida T.

Ann. N. Y. Acad. Sci. 622:402-421(1991).

The results of primary culture of endometrial adenocarcinoma and characterization of its established cell line.

Morisawa T.

Nihon Rinsho Saibo Gakkai Zasshi 26:433-442(1987).

HEC-1 cells: establishment of an in vitro experimental system in endometrial carcinoma.

Kawaguchi M.

(In book chapter) Cell and molecular biology of endometrial carcinoma; Kuramoto H., Nishida M. (eds.); pp.3-34; Springer; Tokyo; Japan (2003).

Web Resources